{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-077a83-2026-09-25T13:01:09+01:00",
    "date": "2026-09-25T13:01:09+01:00",
    "ocid": "ocds-h6vhtk-077a83",
    "description": "This is a Provider Selection Regime (PSR) contract modification notice, under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally modified. Decision makers: Cabinet No conflicts of interest were identified or registered. Conflicts of interest are managed using the Council's procedures along with the PSR regulation 21 and guidance",
    "initiationType": "tender",
    "tender": {
        "id": "DN517038",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Sexual Health and Reproductive Services",
        "classification": {
            "scheme": "CPV",
            "id": "85140000",
            "description": "Miscellaneous health services"
        },
        "mainProcurementCategory": "services",
        "lots": [
            {
                "id": "1",
                "description": "The purpose and reasons for the modification are detailed below: Expanding HIV Pre-exposure prophylaxis (PrEP) - HIV PrEP is a vital tool for preventing HIV transmission. The contract currently delivers HIV PrEP but the Council intends to expand access to this to populations currently not accessing the service, including black and minority ethnic groups and women, with new injectable techniques likely to be more acceptable and accessible to these groups Doxycycline post-exposure prophylaxis (Doxy-PEP) - The UK has released its first national clinical guidelines for doxycycline post-exposure prophylaxis (Doxy-PEP) to prevent syphilis and chlamydia. New Doxy-PEP drug interventions are available and the Council is seeking to implement this guidance using new interventions. Integration of Tuberculosis (TB) testing - The Council is seeking to integrate testing of viral Hepatitis B and C and Tuberculosis (TB) into the service because these conditions can be effectively co-targeted with significant overlap with respect to specific cohorts at high risk. There is a high co-infection rate for TB and HIV. Testing at the same time allows for faster diagnosis, better treatment planning and helps prevent serious illness and spread. Whilst there is an existing TB prevention and control service which is delivered by the same provider (LUHFT) it is not commissioned by LCC and it does not offer latent TB screening. Adding TB testing to the existing contract will enable more effective and efficient targeting of population groups at increased risk of TB. The contracted provider is already targeting these at risk groups for STI and BBV screening.",
                "contractPeriod": {
                    "durationInDays": 2880
                }
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UKD72"
                    }
                ],
                "relatedLot": "1"
            }
        ]
    },
    "awards": [
        {
            "id": "090979-2026-DN517038-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-NHS-REM",
                    "name": "Liverpool University Hospitals NHS Foundation Trust"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-145191",
            "name": "Liverpool City Council",
            "identifier": {
                "legalName": "Liverpool City Council",
                "noIdentifierRationale": "notOnAnyRegister"
            },
            "address": {
                "streetAddress": "Cunard Building",
                "locality": "Liverpool",
                "region": "UKD72",
                "postalCode": "L31DS",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Emma Hardman",
                "email": "emma.hardman@liverpool.gov.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://liverpool.gov.uk/business/procurement-and-contracts/"
            }
        },
        {
            "id": "GB-NHS-REM",
            "name": "Liverpool University Hospitals NHS Foundation Trust",
            "identifier": {
                "legalName": "Liverpool University Hospitals NHS Foundation Trust",
                "id": "REM",
                "scheme": "GB-NHS"
            },
            "address": {
                "streetAddress": "University Hospital Aintree, Broadgreen Hospital",
                "locality": "Liverpool",
                "region": "UKD72",
                "postalCode": "L143LB",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "commercialprocurement@liverpool.gov.uk"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-4530",
            "name": "Liverpool City Council",
            "identifier": {
                "legalName": "Liverpool City Council"
            },
            "address": {
                "locality": "Liverpool",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "id": "GB-FTS-145191",
        "name": "Liverpool City Council"
    },
    "contracts": [
        {
            "id": "090979-2026-DN517038-1",
            "awardID": "090979-2026-DN517038-1",
            "status": "active",
            "value": {
                "amount": 52376880,
                "currency": "GBP"
            },
            "dateSigned": "2026-08-20T00:00:00+01:00",
            "period": {
                "durationInDays": 2880
            },
            "items": [
                {
                    "id": "1",
                    "classification": {
                        "scheme": "CPV",
                        "id": "85100000",
                        "description": "Health services"
                    },
                    "deliveryAddresses": [
                        {
                            "region": "UKD72"
                        }
                    ],
                    "relatedLot": "1"
                }
            ],
            "amendments": [
                {
                    "id": "1",
                    "description": "The modification will continue previously approved service enhancements and support the expansion of key sexual health interventions for the remainder of the contract term. This includes widening access to HIV Pre-Exposure Prophylaxis (PrEP), implementing new Doxycycline Post-Exposure Prophylaxis (Doxy-PEP) interventions in line with national clinical guidance, and integrating Tuberculosis (TB) testing alongside existing STI and blood-borne virus screening services to improve outcomes for high-risk populations. The contract is also being extended by the full three-year option period. The service has been operational for over four years and continues to meet or exceed all key performance indicators, critical performance measures, and social value requirements. The extension option was provided for in the original procurement and hence there is no change to the lifetime value of the contract as a result of exercising this option.",
                    "rationale": "Need for additional works, services or supplies by the original contractor/concessionaire: This is a permitted modification under regulation 13(3)(d) of the Provider Selection Regime Regulations 2023, a contract may be modified where the change is required in response to external factors beyond the control of both the relevant authority and the provider, The modification does not alter the overall nature of the current contract. The contract was varied to support the delivery of enhanced sexual health and HIV prevention initiatives, including expanded access to HIV PrEP, the introduction of Doxy-PEP for the prevention of syphilis and chlamydia, and increased TB testing and treatment pathways for at-risk populations. Additional funding was provided to create capacity for integrated TB advice, testing and referral services within the contract. As Liverpool's designated sexual health provider, Axess implemented these enhanced interventions, which continue to support the objectives of Liverpool's Sexual & Reproductive Health and HIV Strategy by reducing inequalities, improving access to preventative services and strengthening health outcomes. The continuation of the variation throughout the proposed three-year extension period will ensure these interventions remain embedded within service delivery and allow the provider to continue meeting current and emerging population health needs."
                }
            ]
        }
    ],
    "links": [
        {
            "rel": "prev",
            "href": "https://ted.europa.eu/udl?uri=TED:NOTICE:999999-2099:TEXT:EN:HTML"
        }
    ],
    "language": "en"
}